跳至主要内容
临床试验/ACTRN12615001244594
ACTRN12615001244594已完成未知

Comparative physiological evaluation with diaphragmatic ultrasound of the application of oxygen-therapy through a Venturi mask or a nasal high-flow device in patients recovering from severe exacerbation of chronic respiratory failure.

Federico Longhini, MD0 个研究点目标入组 30 人开始时间: 2015年11月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • All the patients meeting the following criteria will be eligible for the study: 1) age equal or greater than 18 years; 2) presence of consciousness; 3) previous NIV for at least 24 hours due to SE-CRF; 4) pH greater than 7.34; 5) respiratory rate (RR) less than or equal to 30 breaths/min.

排除标准

  • Patients will be excluded if they meet one or more of the following criteria:
  • 1.refusal of patient's consent;
  • 2.Hemodynamic instability, as defined by a systolic blood pressure < 90 mmHg despite volemic optimizationn, or use of vasoactive agents, i.e. vasopressin or epinephrine at any dosage, norepinephrine > 0.2 mcg/kg/min, dopamine or dobutamine > 5 mcg/kg/min;
  • 3.major cardiac arrhythmia or electrographic signs of ischemia;
  • 4.use of accessory muscles with dyspnoea;
  • 5.pregnancy.
  • The protocol will be interrupted if:
  • 1.agitation or mental status alteration
  • 2.increase use of accessory muscles and/or dyspnoea
  • 3.pH < 7.30
  • 4.systolic blood pressure < 90 mmHg
  • 5.onset of new cardiac arrhythmia

研究者

发起方
Federico Longhini, MD

相似试验

Comparative physiological evaluation with... | 临床试验